Zosano Pharma Corp Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-06-24: Study NCT04969497; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2019-10-03: Study NCT04066023; Company role Lead sponsor; Phase Phase 2, Phase 3; Status Completed.
- 2019-05-29: Study NCT03978403; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2018-11-01: Study NCT03708744; Company role Lead sponsor; Phase Phase 1; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-06-24 | NCT04969497 Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers | Lead sponsor | Phase 1 | Completed | Migraine | 48 | 2021-09-02 |
| 2019-10-03 | NCT04066023 Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches | Lead sponsor | Phase 2, Phase 3 | Completed Results posted | Cluster Headache | 42 | 2021-04-14 |
| 2019-05-29 | NCT03978403 A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers | Lead sponsor | Phase 1 | Completed Results posted | Migraine | 24 | 2019-06-28 |
| 2018-11-01 | NCT03708744 A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers | Lead sponsor | Phase 1 | Completed Results posted | Migraine | 24 | 2018-11-20 |
| 2017-11-07 | NCT03282227 A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine | Lead sponsor | Phase 3 | Completed Results posted | Migraine | 342 | 2019-05-17 |
| 2016-06 | NCT02745392 Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine | Lead sponsor | Phase 2, Phase 3 | Completed Results posted | Acute Migraine | 365 | 2017-01 |
| 2015-06 | NCT02478879 A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen | Lead sponsor | Phase 1 | Completed | Postmenopausal Osteoporosis | 24 | 2015-12 |
| 2015-01 | NCT02459938 Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia | Lead sponsor | Phase 1 | Completed | Hypoglycemia | 16 | 2015-10 |
| 2007-06 | NCT00489918 Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis | Lead sponsor | Phase 2 | Completed Results posted | Osteoporosis | 165 | 2008-08 |